Probing the brain–body connection using transcranial magnetic stimulation (Tms): Validating a promising tool to provide biomarkers of neuroplasticity and central nervous system function

Abstract

Transcranial magnetic stimulation (TMS) is a non‐invasive method used to investigate neurophysiological integrity of the human neuromotor system. We describe in detail, the method-ology of a single pulse TMS protocol that was performed in a large cohort of people (n = 110) with multiple sclerosis (MS). The aim was to establish and validate a core‐set of TMS variables that pre-dicted typical MS clinical outcomes: walking speed, hand dexterity, fatigue, and cognitive processing speed. We provide a brief and simple methodological pipeline to examine excitatory and inhibitory corticospinal mechanisms in MS that map to clinical status. Delayed and longer ipsilat-eral silent period (a measure of transcallosal inhibition; the influence of one brain hemisphere’s activity over the other), longer cortical silent period (suggestive of greater corticospinal inhibition via GABA) and higher resting motor threshold (lower corticospinal excitability) most strongly related to clinical outcomes, especially when measured in the hemisphere corresponding to the weaker hand. Greater interhemispheric asymmetry (imbalance between hemispheres) correlated with poorer performance in the greatest number of clinical outcomes. We also show, not surprisingly, that TMS variables related more strongly to motor outcomes than non‐motor outcomes. As it was validated in a large sample of patients with varying severities of central nervous system dysfunc-tion, the protocol described herein can be used by investigators and clinicians alike to investigate the role of TMS as a biomarker in MS and other central nervous system disorders.